SARS-CoV-2 evolution : emergence of the "Californian" and "Indian" variants / Eric Vail.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Spoken recording |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2021.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Research and clinical interviews.
|
| Subjects: | |
| Online Access: | Henry Stewart Talks: Biomedical & Life Sciences Series |
MARC
| LEADER | 00000nim a2200000 a 4500 | ||
|---|---|---|---|
| 005 | 20230810231413.0 | ||
| 006 | m o h | ||
| 007 | cr nna|||||||| | ||
| 007 | sr |mnnnnnzne| | ||
| 008 | 210704s2021 enk|||||o|||||| | eng d | ||
| 028 | 5 | 0 | |a 8229 |b Henry Stewart Talks |
| 035 | |a (HSTalks)HST8229 | ||
| 040 | |a HSTalks |b eng |d ATU | ||
| 100 | 1 | |a Vail, Eric, |u (Cedars-Sinai Medical Center, USA), |e speaker | |
| 245 | 1 | 0 | |a SARS-CoV-2 evolution : |b emergence of the "Californian" and "Indian" variants / |c Eric Vail. |
| 264 | 1 | |a London : |b Henry Stewart Talks, |c 2021. | |
| 300 | |a 1 streaming audio file (14 min.). | ||
| 336 | |a spoken word |b spw |2 rdacontent | ||
| 344 | |a digital | ||
| 347 | |a audio file | ||
| 490 | 1 | |a Research and clinical interviews, |x 2056-452X | |
| 500 | |a Audio interview. | ||
| 500 | |a Title from title frames. | ||
| 505 | 0 | |a Contents: Status and efficiency of SARS-CoV-2 genetic surveillance in the USA -- The identification of a "Californian" variant, Epsilon, following a surge in Covid-19 cases in California in early 2021 -- The genetic characteristics of the Epsilon variant and the phenotypic advantages they provide -- The more recent identification of a separate variant from India, the Delta variant: key characteristics and their implications. | |
| 538 | |a Mode of access: World Wide Web. | ||
| 650 | 0 | |a Coronaviruses. |9 347261 | |
| 650 | 0 | |a COVID-19 (Disease) |x Genetic aspects. |9 630688 | |
| 650 | 0 | |a Covid-19 (Disease) |x Research |9 805414 | |
| 650 | 0 | |a Nucleotide sequence. |9 321501 | |
| 650 | 0 | |a Viruses |x Evolution. |9 338185 | |
| 650 | 2 | |a COVID-19 |x epidemiology. |9 520892 | |
| 650 | 2 | |a COVID-19 |x virology. |9 521100 | |
| 650 | 2 | |a Epidemiological Monitoring. |9 516658 | |
| 650 | 2 | |a Evolution, Molecular. |9 358242 | |
| 650 | 2 | |a Genetic Variation. |9 364487 | |
| 650 | 2 | |a Genome, Viral. |9 358760 | |
| 650 | 2 | |a Mutation. |9 361021 | |
| 650 | 2 | |a SARS-CoV-2 |x genetics. |9 521825 | |
| 650 | 2 | |a SARS-CoV-2 |x isolation & purification. |9 521916 | |
| 650 | 2 | |a Sequence Analysis. |9 358073 | |
| 830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Research and clinical interviews. | |
| 856 | 4 | 0 | |u http://ezproxy.aut.ac.nz/login?url=https://hstalks.com/bs/4683/ |z Henry Stewart Talks: Biomedical & Life Sciences |
| 856 | 4 | 2 | |u http://ezproxy.aut.ac.nz/login?url=https://hstalks.com/bs/p/1060/ |3 Series |
| 907 | |a .b30838794 |b 27-10-21 |c 22-07-21 | ||
| 942 | |c SR | ||
| 998 | |a none |b 27-10-21 |c m |d i |e - |f eng |g enk |h 0 | ||
| 999 | |c 1641448 |d 1641448 | ||